This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Angiogenesis Inhibitors; Bevacizumab; Biomarkers, Tumor; Induction Chemotherapy; Neurofibromatosis 2; Neuroma, Acoustic
|
|
information resource reference
|
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454.
|
|
label
|
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.
|